Monitoring long-term treatment After glaucoma treatment has started patients are generally reassessed by an Ophthalmologist at three to 12 month intervals depending on the patient's risk profile, degree of glaucoma progression and ability to self-manage their treatment regimen. Patients who are not achieving their IOP target will be seen more frequently. Regular glaucoma medicine reviews in primary care are likely to assist with treatment adherence and emphasise the need for regular eye examination of other family members.
The glaucoma medicine review check-list:
1. Ensure the patient is persisting with treatment, has sufficient medicine until their next prescription renewal or repeat and that they understand the potential consequences if treatment is stopped 2. Confirm the patient is using the Double DOT method of medicine administration